BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23402815)

  • 1. The microtubule binding drug EM011 inhibits the growth of paediatric low grade gliomas.
    Ajeawung NF; Joshi HC; Kamnasaran D
    Cancer Lett; 2013 Jul; 335(1):109-18. PubMed ID: 23402815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viability screen on pediatric low grade glioma cell lines unveils a novel anti-cancer drug of the steroid biosynthesis inhibitor family.
    Ajeawung NF; Maltais R; Jones C; Poirier D; Kamnasaran D
    Cancer Lett; 2013 Mar; 330(1):96-105. PubMed ID: 23201138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance-associated protein-overexpressing teniposide-resistant human lymphomas undergo apoptosis by a tubulin-binding agent.
    Aneja R; Liu M; Yates C; Gao J; Dong X; Zhou B; Vangapandu SN; Zhou J; Joshi HC
    Cancer Res; 2008 Mar; 68(5):1495-503. PubMed ID: 18316614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-resistant T-lymphoid tumors undergo apoptosis selectively in response to an antimicrotubule agent, EM011.
    Aneja R; Zhou J; Vangapandu SN; Zhou B; Chandra R; Joshi HC
    Blood; 2006 Mar; 107(6):2486-92. PubMed ID: 16282340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel microtubule-modulating noscapinoid triggers apoptosis by inducing spindle multipolarity via centrosome amplification and declustering.
    Karna P; Rida PC; Pannu V; Gupta KK; Dalton WB; Joshi H; Yang VW; Zhou J; Aneja R
    Cell Death Differ; 2011 Apr; 18(4):632-44. PubMed ID: 21052096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evaluation of dipotassium bisperoxo (picolinato) oxovanadate V for the treatment of pediatric low-grade gliomas.
    Ajeawung NF; Faure R; Jones C; Kamnasaran D
    Future Oncol; 2013 Aug; 9(8):1215-29. PubMed ID: 23902250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coadministration of sorafenib with rottlerin potently inhibits cell proliferation and migration in human malignant glioma cells.
    Jane EP; Premkumar DR; Pollack IF
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1070-80. PubMed ID: 16959960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EM011 activates a survivin-dependent apoptotic program in human non-small cell lung cancer cells.
    Karna P; Sharp SM; Yates C; Prakash S; Aneja R
    Mol Cancer; 2009 Oct; 8():93. PubMed ID: 19878573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo.
    Zhang T; Guan M; Xu C; Chen Y; Lu Y
    Life Sci; 2007 Sep; 81(16):1256-63. PubMed ID: 17919663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for low-grade gliomas.
    Reddy AT; Packer RJ
    Childs Nerv Syst; 1999 Oct; 15(10):506-13. PubMed ID: 10550582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel microtubule-modulating agent induces mitochondrially driven caspase-dependent apoptosis via mitotic checkpoint activation in human prostate cancer cells.
    Aneja R; Miyagi T; Karna P; Ezell T; Shukla D; Vij Gupta M; Yates C; Chinni SR; Zhau H; Chung LW; Joshi HC
    Eur J Cancer; 2010 Jun; 46(9):1668-78. PubMed ID: 20303260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways.
    Chen YC; Lu PH; Pan SL; Teng CM; Kuo SC; Lin TP; Ho YF; Huang YC; Guh JH
    Biochem Pharmacol; 2007 Jun; 74(1):10-9. PubMed ID: 17475221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The microtubule inhibiting agent epothilone B antagonizes glioma cell motility associated with reorganization of the actin-binding protein α-actinin 4.
    Henry WI; Dubois J; Quick QA
    Oncol Rep; 2011 Mar; 25(3):887-93. PubMed ID: 21234524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epothilone B inhibits migration of glioblastoma cells by inducing microtubule catastrophes and affecting EB1 accumulation at microtubule plus ends.
    Pagano A; Honoré S; Mohan R; Berges R; Akhmanova A; Braguer D
    Biochem Pharmacol; 2012 Aug; 84(4):432-43. PubMed ID: 22634050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy using Notch and Akt inhibitors is effective for suppressing invasion but not proliferation in glioma cells.
    Jin R; Nakada M; Teng L; Furuta T; Sabit H; Hayashi Y; Demuth T; Hirao A; Sato H; Zhao G; Hamada J
    Neurosci Lett; 2013 Feb; 534():316-21. PubMed ID: 23262078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel microtubule-modulating agent EM011 inhibits angiogenesis by repressing the HIF-1α axis and disrupting cell polarity and migration.
    Karna P; Rida PC; Turaga RC; Gao J; Gupta M; Fritz A; Werner E; Yates C; Zhou J; Aneja R
    Carcinogenesis; 2012 Sep; 33(9):1769-81. PubMed ID: 22678119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetramethylpyrazine-mediated suppression of C6 gliomas involves inhibition of chemokine receptor CXCR4 expression.
    Yu K; Chen Z; Pan X; Yang Y; Tian S; Zhang J; Ge J; Ambati B; Zhuang J
    Oncol Rep; 2012 Sep; 28(3):955-60. PubMed ID: 22710373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-methoxyestradiol induces morpho-functional changes and impairs the microtubular system in mouse neuroblastoma and rat glioma cells.
    Manca P; Chisu V
    Arch Ital Biol; 2010 Mar; 148(1):11-21. PubMed ID: 20426250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant glioma.
    Sathornsumetee S; Hjelmeland AB; Keir ST; McLendon RE; Batt D; Ramsey T; Yusuff N; Rasheed BK; Kieran MW; Laforme A; Bigner DD; Friedman HS; Rich JN
    Cancer Res; 2006 Sep; 66(17):8722-30. PubMed ID: 16951188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-(Naphthalene-1-yl)-6-pyrrolidinyl-4-quinazolinone inhibits skin cancer M21 cell proliferation through aberrant expression of microtubules and the cell cycle.
    Wu YC; Hour MJ; Leung WC; Wu CY; Liu WZ; Chang YH; Lee HZ
    J Pharmacol Exp Ther; 2011 Sep; 338(3):942-51. PubMed ID: 21652781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.